CBS 2019
CBSMD教育中心
English

推荐文献

科研文章

荐读文献

Cholesterol-Lowering Agents Current Perspectives on Coronavirus Disease 2019 and Cardiovascular Disease: A White Paper by the JAHA Editors Cardiorespiratory Fitness and Mortality in Healthy Men and Women Improving the Design of Future PCI Trials for Stable Coronary Artery Disease: JACC State-of-the-Art Review In-Hospital Costs and Costs of Complications of Chronic Total Occlusion Angioplasty Insights From the OPEN-CTO Registry Home-Based Cardiac Rehabilitation: A Scientific Statement From the American Association of Cardiovascular and Pulmonary Rehabilitation, the American Heart Association, and the American College of Cardiology Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease Catheterization Laboratory Considerations During the Coronavirus (COVID-19) Pandemic: From the ACC’s Interventional Council and SCAI Know Diabetes by Heart: A Partnership to Improve Cardiovascular Outcomes in Type 2 Diabetes Mellitus Classification of Deaths in Cardiovascular Outcomes Trials Known Unknowns and Unknown Unknowns
|<<... 18 19 20 21 22 23 24 25 >>|

Original Research2020 Nov, 76 (19) 2197–2207.

JOURNAL：J Am Coll Cardiol. Article Link

Influence of LDL-Cholesterol Lowering on Cardiovascular Outcomes in Patients With Diabetes Mellitus Undergoing Coronary Revascularization

ME Farkouh , LC Godoy, V Fuster et al. Keywords: diabetes; coronary revascularization; LDL-Cholesterol

Full Text PDF

>CBS CBS 2019

> CBS 2019

> CBS 2019 注册

> CBS 2019 会议日程

> CBS 2019 学术征集

> CBS 2019 热点

 CBSMD

> CBSMD 网站注册

> 教育中心

> 荐读文献

> Top 10 阅读文献

> 文献导读
CBS 2019 CBS 2019 主席团 教育中心 科研动态
Copyright ⓒ CBS MD Nanjing China. All rights reserved. 京ICP备16025898号-11
联系我们| Top